BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181214
DTEND;VALUE=DATE:20181217
DTSTAMP:20260515T033754
CREATED:20171204T015507Z
LAST-MODIFIED:20171204T020628Z
UID:4943-1544745600-1545004799@www.pharmajournalist.com
SUMMARY:Myanmar Lab Expo 2018
DESCRIPTION:The most definitive event for Laboratory Industry in Myanmar. Gathering the region’s hospital\, Diagnostic\, Laboratory\, Analytical\, Biotechnology and Scientific Instruments & Technology sectors in one convenient location and providing the perfect platform to discover the latest industry innovations\, to network and do business.
URL:https://www.pharmajournalist.com/event/myanmar-lab-expo-2018/
LOCATION:Rose Garden Hotel\, Yangon\, Myanmar
ORGANIZER;CN="VEAS Co.%2C Ltd":MAILTO:info@veas.com.vn
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181214
DTEND;VALUE=DATE:20181217
DTSTAMP:20260515T033754
CREATED:20171204T015322Z
LAST-MODIFIED:20171204T020748Z
UID:4939-1544745600-1545004799@www.pharmajournalist.com
SUMMARY:Myanmar Phar-Med 2018
DESCRIPTION:This is the biggest trade fair for the medical industry in Myanmar\, focused on hospital\, diagnostic\, pharmaceutical\, medical and rehabilitation sectors\, providing the perfect platform to discover the latest industry innovations\, to network and do business.
URL:https://www.pharmajournalist.com/event/myanmar-phar-med-2018/
LOCATION:Rose Garden Hotel\, Yangon\, Myanmar
ORGANIZER;CN="VEAS Co.%2C Ltd":MAILTO:info@veas.com.vn
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181212
DTEND;VALUE=DATE:20181214
DTSTAMP:20260515T033754
CREATED:20181025T095842Z
LAST-MODIFIED:20181025T095842Z
UID:18110-1544572800-1544745599@www.pharmajournalist.com
SUMMARY:AI & Big Data for Pharma\, part of DATAx
DESCRIPTION:AI & Big Data for Pharma Summit 2018: Leverage Data Analytics to Deliver Patient-Centric Outcomes \n \nWith the race to adopt data and analytics\, the pharma ecosystem is transforming to keep up with the rapid pace of change. Unprecedented volumes of real-time data are right at our fingertips\, leaders must think strategically about how to gather\, harvest\, and leverage insights. The is the must-attend event to enhance AI and analytics capability in drug discovery and development\, translate patient data into meaningful insights\, and master the art of a seamless journey in pharma supply chain and logistics. \nTopic Areas Covered Include: \n\nLeveraging real time data in R&D and challenges of unstructured data\nAccelerating drug discovery and development through advanced analytics\nStreamlining clinical trial efficiency using AI and machine learning\nCultivating industry partnerships to build knowledge networks\nThe changing face of pharma and how the industry is evolving\nRise of the digital patient: Personalised patient care\, precision medicine and AI\nManaging demand forecasting\, planning\, and reduce waste in commercial analytics\nTransparency in the global supply chain and optimising robotics and AI\n\nFind out more information and register here: http://bit.ly/2O3MQ1Z
URL:https://www.pharmajournalist.com/event/ai-big-data-for-pharma/
LOCATION:New York Hilton Midtown
ORGANIZER;CN="The Innovation Enterprise Ltd.":MAILTO:http://bit.ly/2O3MQ1Z
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181212
DTEND;VALUE=DATE:20181214
DTSTAMP:20260515T033754
CREATED:20181005T130934Z
LAST-MODIFIED:20181005T130934Z
UID:17934-1544572800-1544745599@www.pharmajournalist.com
SUMMARY:7th Lung Cancer Screening & Continuum of Care
DESCRIPTION:ACI is excited to announce our 7th Lung Cancer Screening & Continuum of Care Conference on December 12-13\, 2018. A dedicated forum to learn and network with representatives from organizations nationwide that are prepared to deliver superior service in thoracic oncology. \nOur event will be an exploration of techniques and policy changes to better fit lung screening programs through case studies\, research findings and organizational models from renowned healthcare and radiology institutions. The top thoracic oncology programs in the country will showcase their successes and share strategies in achieving excellence in patient care and cost-effective management. \n \nThis two-day event will focus on implementing lung screening programs and services to maximize competitive advantage\, meet increased demand and exceed patient satisfaction. The goal of this event is to bring industry leaders together\, highlight the best practice achievements\, and discuss the current issues and developments in imaging services for the thoracic oncology community. \nLung cancer is the leading cause of cancer-related deaths in the United States. This largely stems from lung cancer’s minimal symptoms in its early stages\, which is when the disease is most treatable. For this reason\, there is a push for regions to offer screening services for their populations\, enabling potential patients to receive care at the most opportune time. Providing this service to potential patients comes with its own challenges\, such as motivating patients to get screened regularly\, generating funding for these services\, raising awareness in your community and many more.
URL:https://www.pharmajournalist.com/event/7th-lung-cancer-screening-continuum-of-care/
LOCATION:Tampa\, FL\, USA\, FL\, United States
ORGANIZER;CN="ACI":MAILTO:rafael@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181211
DTEND;VALUE=DATE:20181214
DTSTAMP:20260515T033754
CREATED:20181031T155925Z
LAST-MODIFIED:20181031T160117Z
UID:18205-1544486400-1544745599@www.pharmajournalist.com
SUMMARY:Tumor Targeted Lymphocyte Summit
DESCRIPTION:The Tumor Targeted Lymphocyte Summit is the first\, dedicated meeting that unites the expert community working in TIL and CTL therapies to network\, learn and determine strategies to enhance the efficacy of this adoptive cell therapy in solid tumors. \n \nAs CAR-T fails in the fight to deliver efficacy in solid tumors\, the field is desperately exploring alternative adoptive cell therapies which are strong enough to rise to the challenge. TILs and CTLs have successfully been utilized in melanoma and now with patient demand growing\, TIL-based therapies are fast becoming a more attractive approach to solid tumors. \nSounds interesting? Find out more – get free event brochure here: http://bit.ly/2zgKRSx
URL:https://www.pharmajournalist.com/event/tumor-targeted-lymphocyte-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20181213
DTSTAMP:20260515T033754
CREATED:20181016T110516Z
LAST-MODIFIED:20181016T110516Z
UID:18021-1544400000-1544659199@www.pharmajournalist.com
SUMMARY:Antigen-Specific Immune Tolerance Europe Summit
DESCRIPTION:Optimizing the Discovery\, Translation and Clinical Development of Safe and Effective Antigen-Specific Immune Tolerance Inducing Therapies to Treat Autoimmune Diseases. \n \nThe clinical heterogeneity of more than 80 autoimmune diseases presents a significant challenge with respect to the development of therapies designed to re-establish self-tolerance. As the first generation of antigen-specific immune tolerance therapies enters the clinic and excitement around the recent deals\, partnerships\, IPOs and investments reaching new heights\, now is the time for an industry forum for large pharma\, pioneering biotech and academia to unite. \nTackling key R&D challenges\, such as antigen identification\, animal model predictability\, translation and clinical design\, the Antigen-Specific Immune Tolerance Europe Summit is the first European centric\, dedicated platform that brings key decision makers together to successfully translate ground breaking science into a novel class of therapies to treat autoimmunity. \nTo learn more about this event\, and to register online\, visit http://www.as-immunetolerance-eu.com/
URL:https://www.pharmajournalist.com/event/antigen-specific-immune-tolerance-europe-summit/
LOCATION:Park Plaza Victoria\, 239 Vauxhall Bridge Road\, London\, SW1V 1EQ\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20181212
DTSTAMP:20260515T033754
CREATED:20180613T100920Z
LAST-MODIFIED:20180613T101345Z
UID:16240-1544400000-1544572799@www.pharmajournalist.com
SUMMARY:Cold Chain Distribution
DESCRIPTION:SMi proudly presents the 13th annual Cold Chain Distribution Conference and Exhibition\, taking place at the Copthorne Tara Hotel in Kensington\, London between the 10th – 11th December. \n\nThe 13th annual event will specifically focus on recent advances in temperature-controlled logistic solutions and the impact of regulatory changes on this multi-billion-dollar industry. The event will also address the impact of the overwhelming digitalisation of the industry and how companies\, from biotech’s to pharma\, need to adapt\, as well as the crucial challenges of supply chain visibility and data integrity in the cold chain industry. \nThe two-day event will also look at various developments within the industry\, guiding companies on how best to ensure costs are kept low\, and quality remains high\, whilst simultaneously staying compliant to global regulations. \nThis year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations and issues in the field of temperature-controlled distribution. \nChairs for 2018: \n\nBob Hayes\, Director\, SeerPharma (UK)\nTony Wright\, CEO\, Exelsius\n\nFeatured Speakers: \n\nBob Hayes\, Director\, SeerPharma (UK)\nStephen Mitchell\, Quality Lead Logistics Partnerships\, GSK\nGianneOlaes-Dénis\, Supply Chain Quality Manager\, SanofiGenzymeEurope\nStefan Braun\, Managing Director\, SmartCAE\nGianpieroLorusso\, Director\, Supply Operations and GS\, Merck\nFrancicso Rizzuto\, Cargo Specialist\, Manager for Europe\, IATA\nMarco Gaudesi\, Pharmacist – GDP and Cold Chain Referent\, MSF\nHenk Mulder\, Head\, Digital Cargo\, IATA\n\nKey Highlights this December: \n\nEvaluate the current GDP guidelines\, with reference to the recently published PQG/ECA guide and discover the implications for everyday practice\nExplore the overwhelming digitalisation of the supply chain and identify the subsequent security issues involved\nDiscover the temperature-controlled logistic solutions to best optimize your supply chain\nDiscuss the technical agreements within the supply chain and find out what questions you should be asking\nIdentify the challenges for the supply chain within emerging markets and discover the best solutions for optimization of your process\n\nView the full agenda online: www.coldchain-distribution.com/pj \nEARLY-BIRD RATES: \n\nBOOK BY 29TH JUNE AND SAVE £400\nBOOK BY 28TH SEPTEMBER AND SAVE £300\nBOOK BY 31ST OCTOBER AND SAVE £100\n\nTo learn more about SMi’s Cold Chain Distribution\, and to register online\, visit www.coldchain-distribution.com/pj
URL:https://www.pharmajournalist.com/event/cold-chain-distribution/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, United Kingdom
ORGANIZER;CN="SMi Events":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181206
DTEND;VALUE=DATE:20181208
DTSTAMP:20260515T033754
CREATED:20180503T162044Z
LAST-MODIFIED:20180530T113851Z
UID:15611-1544054400-1544227199@www.pharmajournalist.com
SUMMARY:The Digital Pathology Congress
DESCRIPTION:The congress will have expanded coverage of new areas such as AI and computational pathology alongside the latest case studies and applications. To complement the latest scientific presentations\, the conference will comprise of a vibrant exhibition room full of technology providers showcasing their technologies and other solutions; networking breaks allowing interaction with your peers; poster presentation sessions; and incisive Q&A panel discussions. Whether looking to hear more about the adoption and integration of digital pathology; seeking collaborations and tools to increase workflow; or uncover the latest developments in automated image analysis; the Congress is one not to be missed! \nTo learn more about this event\, and to register online\, visit https://goo.gl/42HTeh
URL:https://www.pharmajournalist.com/event/the-digital-pathology-congress/
LOCATION:London Heathrow Marriott Hotel\, London\, UK
ORGANIZER;CN="Global Engage":MAILTO:anna@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181204
DTEND;VALUE=DATE:20181206
DTSTAMP:20260515T033754
CREATED:20181010T095555Z
LAST-MODIFIED:20181010T095555Z
UID:17959-1543881600-1544054399@www.pharmajournalist.com
SUMMARY:BioFIT
DESCRIPTION:EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT  \nWith the highest attending rate of TTOs\, research institutes and academia together with big pharma\, emerging and small biotech\, diagnostics companies\, pre-seed / seed / Series A investors\, BioFIT is the leading partnering event in Europe for technology transfer\, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed\, seed and Series A investment in Life Sciences. \nWHY ATTEND BIOFIT? \nOut of 1\,000 BioFIT attendees\, 1\,000 deals have been generated. The breakdown in terms of nature of deals is the following: \n\n35% of collaborative research projects\n30% of licensing deals\n15% of equity investment deals\n20% of services deals\n\nEstimate based on the measurement of 2015 and 2016 delegates’ outcomes \nKEY FIGURES: \n\n1\,200+ delegates\n800+ organisations\n35+ countries represented\n1\,000 deals generated in 2017\n\nINSIDE THE EVENT: \n\nA business convention with pre-qualified one-to-one meetings (partneringONE platform from EBD Group)\nIdentification of would-be CEOs\nConferences and roundtable discussions\nOral presentations of start-ups and licensing opportunities stemming from academia\nAn exhibition area\nInformal networking evenings\n\nWebsite: www.biofit-event.com\nTwitter: @BIOFIT_EVENT \nContact:\nMargaux Satola\nBusiness Development Manager\nmsatola@eurasante.com\n+33 (0)3 59 39 01 82
URL:https://www.pharmajournalist.com/event/biofit/
LOCATION:Lille Grand Palais  1 boulevard des Cités Unies  59000 Lille\, FRANCE\, France
ORGANIZER;CN="Eurasant%C3%A9%2C NHL Cluster%2C Alsace BioValley":MAILTO:biofit@eurasante.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181204
DTEND;VALUE=DATE:20181207
DTSTAMP:20260515T033754
CREATED:20180926T144030Z
LAST-MODIFIED:20180926T144030Z
UID:17791-1543881600-1544140799@www.pharmajournalist.com
SUMMARY:CBI’s Clinical Trial Agreement Series
DESCRIPTION:Designed to maximize your time out of the office\, CBI’s three-day Clinical Trial Agreement conference series allows your team to select the content that best meets your business objectives. Attend your preferred event or BOTH for maximum value\, learning and benchmarking. The Clinical Trial Legal and Contracting Forum\, taking place December 4-5 in Philadelphia\, serves as the only meeting that is singularly focused on the detailed legal and contracting issues that relate to clinical agreements of all types. The Clinical Trial Financial Management summit\, taking place December 5-6 in Philadelphia\, is designed to arm sponsors\, CROs\, AMCs and sites with the insights they need to develop\, negotiated and manage the financial aspects of clinical trial agreements. \nTo learn more about this event\, visit www.cbinet.com/ctafinance
URL:https://www.pharmajournalist.com/event/cbis-clinical-trial-agreement-series/
LOCATION:Wyndham Philadelphia Historic District\, 400 Arch Street\, Philadelphia\, PA\, 19106\, United States
ORGANIZER;CN="CBI%2C a division of UBM Americas":MAILTO:cbireg@cbinet.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181204
DTEND;VALUE=DATE:20181206
DTSTAMP:20260515T033754
CREATED:20180821T073305Z
LAST-MODIFIED:20180821T073427Z
UID:17294-1543881600-1544054399@www.pharmajournalist.com
SUMMARY:Skin Microbiome Asia
DESCRIPTION:Skin Microbiome Asia | 4-5 December 2018 | Hong Kong – As K-Beauty and J-Beauty continue to storm the world\, beauty start-ups are also emerging from Australia\, India and across Southeast Asia.  China\, Singapore and Hong Kong remain mecca markets for international companies launching products into the region. There has never been a better time for cosmetics professionals to meet in Asia. \n \n150+ industry experts will be gathering in Hong Kong this December to learn about the science behind the products from companies like Unilever\, Cosmax\, Mother Dirt and more. \nJoin multinationals\, independent beauty brands\, sequencing companies\, regulators\, pharma & biotech companies and academia to build your network throughout Asia Pacific. \nInterested to learn more? Take a look at our agenda here: http://bit.ly/SkinAsiaAgenda \nOr take advantage of our Super Early Bird Pricing and book your pass here: http://bit.ly/SkinAsiaRegistration \nPraise for the event: \n“An incredible event… Fast paced and full of new and relevant information from a variety of perspectives\, each of which provide a complete and extensive snapshot of the industry and the future of microbiome friendly products”  – TrūAura Beauty \n“The value of this conference was absolutely unparalleled! I not only saw many old friends\, collaborators and partners\, but also met many new ones as well.”  – ProdermIQ \nTo learn more about Skin Microbiome Asia\, and to register online\, visit www.skinmicrobiomecongressasia.com
URL:https://www.pharmajournalist.com/event/skin-microbiome-asia/
LOCATION:Hong Kong\, Venue TBC
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181204
DTEND;VALUE=DATE:20181207
DTSTAMP:20260515T033754
CREATED:20180808T120122Z
LAST-MODIFIED:20180808T120525Z
UID:17076-1543881600-1544140799@www.pharmajournalist.com
SUMMARY:4th Annual Oncolytic Virotherapy Summit
DESCRIPTION:The 4th Oncolytic Virotherapy Summit is dedicated to improving the commercial success of oncolytic viruses\, in stand-alone and combination therapies. \n\nAs many oncolytic viruses progress through the clinical pipelines\, drug developers need to ensure that their therapies are safe\, efficacious and commercially viable. Make sure you stay ahead of the game and join Oncolytic Virotherapy Summit\, where you will have an opportunity to pick the brains of 100+ senior industry peers and tackle your challenges in discovery\, clinical development\, manufacturing and regulations of oncolytic virotherapy. \nThis year we will be incorporating commercial insights from companies such as Merck\, Virogen\, Sagetis\, Lokon Pharma\, Replimmune\, Western Oncolytics\, DNAtrix and many more\, which will allow you to learn from their case studies and improve your development strategies. Participate in the interactive roundtable and workshops to build strategies that maximise success in the clinic and commercially. \nSounds interesting? Find out more – get free event brochure here: http://bit.ly/2KzCLIh
URL:https://www.pharmajournalist.com/event/4th-annual-oncolytic-virotherapy-summit/
LOCATION:Hilton Boston Back Bay Hotel\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:maggie.pang@oncolyticvirotherapies.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181130
DTSTAMP:20260515T033754
CREATED:20181005T073033Z
LAST-MODIFIED:20181005T073033Z
UID:17885-1543276800-1543535999@www.pharmajournalist.com
SUMMARY:ICI Europe Summit 2018
DESCRIPTION:ICI Europe Summit 2018 | 27-29 November 2018 | The Sofitel Berlin Kurfuerstendamm\, Berlin \nEvidencing How Checkpoint Combinations Can Enhance Every Stage of the Cancer Immunity Cycle \nRather than covering a random selection of immuno-oncology combinations\, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle\, enhancing the long-term success of immuno-oncology drug development. \n \nCutting through the noise and hype around the immuno-oncology field\, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches. \nDon’t miss this opportunity to join Merck\, Genentech\, AstraZeneca\, Bayer\, Roche and many other leading organisations\, to empower you to make the right decisions with your IO pipeline and lay the foundations for your future success. \nAccess the complete programme to find out more about the speakers and what they will discuss: https://bit.ly/2Rr4TSI \nPharma Journalist readers are eligible for 10% discount to attend. Book online quoting VIP Code 9710PJ and you’ll automatically receive the discount. Applies to new bookings only. Cannot be used in conjunction with other offers. T&Cs apply.
URL:https://www.pharmajournalist.com/event/ici-europe-summit-2018/
LOCATION:The Sofitel Berlin Kurfuerstendamm\, Augsburger Strasse 41\, Berlin\, 10789\, Germany
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181129
DTSTAMP:20260515T033754
CREATED:20180503T161738Z
LAST-MODIFIED:20180530T113649Z
UID:15607-1543276800-1543449599@www.pharmajournalist.com
SUMMARY:The 4BIO Summit: Europe
DESCRIPTION:4Bio Europe will feature the most cutting-edge research and technology developments in the fields of qPCR/dPCR\, NGS\, microfluidics and gene editing. Scientific advancements coupled with cost reductions in these four areas of research have contributed to the improved diagnosis\, monitoring\, and treatment of disease. \nWith similar and shared methods and applications across the four main themes of the meeting\, 4Bio Europe will provide a multi-disciplinary forum in which to discover crossover in your research\, attend the latest cutting-edge talks that appeal to you mostand network with your peers and discover solutions to the whole spectrum of your research all in one location. \nTo learn more about this event\, and to register online\, visit https://goo.gl/Vza4PY
URL:https://www.pharmajournalist.com/event/the-4bio-summit-europe/
LOCATION:Rotterdam\, Netherlands (venue TBC)
ORGANIZER;CN="Global Engage":MAILTO:anna@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181115
DTEND;VALUE=DATE:20181116
DTSTAMP:20260515T033754
CREATED:20181001T120453Z
LAST-MODIFIED:20181001T122503Z
UID:17854-1542240000-1542326399@www.pharmajournalist.com
SUMMARY:17th Pharmacovigilance 2018
DESCRIPTION:17th Pharmacovigilance 2018 \n15th November 2018\, Kohinoor Continental Hotel\, Mumbai\, India \n17th Pharmacovigilance 2018 focuses on the advancements in Pharmacovigilance\, Risk Management\, and Drug Safety. IT emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. \nSPONSORS: \n\nPrincipal Sponsor: Apcer Life Sciences\nGold Sponsor: Syneos Health\nExhibitors: Ab Cube\, Medvigil\, Elsevier\n\nKEY SPEAKERS: \nDDC(I)\, CDSCO (HQ)\, Indian Drug Manufacturers’ Association (IDMA)\, FDA Maharashtra Lupin \, Abbott\, Merck Sharp & Dohme\, Novartis \, Abbott\, AstraZeneca\, Piramal\, Reliance Life Sciences\, GSK\, Mylan Laboratories\, Nishith Desai Associates\, \, Roche Pharmaceuticals\, CliniSearch\, GSK\, Member Editorial Board Journal of Generic Medicines\, England\,  Veeda Clinical Research\, AWINSA Life Sciences\, \nCONFERENCE REGISTRATION: \nIn order to register you can simply Email: kavitha@virtueinsight.co.in or Tel: +91 44 24762472 \n\nEarly Bird Discounted Price (Ends 12th October 2018 ) – 1 Delegate Pass – (INR 10\,000 + GST (18%) per delegate)\nStandard Price (13th October 2018 Onwards) – 1 Delegates – (INR 15\,000 + GST (18%) per delegate)\nConference Sponsor\, Exhibition Stall (Booth) and a paid Speaker slots are also available. We also have some sponsorship opportunities available for the event\, which gives you an opportunity to speak/exhibit\, and create brand awareness. In addition\, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.\n\nGet more from the event\, with a broader scope bringing the whole communications value chain together.
URL:https://www.pharmajournalist.com/event/17th-pharmacovigilance-2018/
LOCATION:Kohinoor Continental Hotel\, Andheri Kurla Road\, Andheri ( E )\, Mumbai – India\, Mumbai\, 400059\, India
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181114
DTEND;VALUE=DATE:20181116
DTSTAMP:20260515T033754
CREATED:20180831T142800Z
LAST-MODIFIED:20180831T142845Z
UID:17481-1542153600-1542326399@www.pharmajournalist.com
SUMMARY:Marketing and Customer Experience USA
DESCRIPTION:Redefine your customer relationships to become a valued healthcare partner\neyeforpharma’s Marketing and Customer Experience USA (November 14-15 2018\, Philadelphia) breaks down the model you need to raise the bar on customer experience and get ROI on marketing strategies. \n \nDigital is dead. Theoretical discussions about the power of technology are obsolete. But pharma has the potential to transform its customer relationships given the right tools. \neyeforpharma is bringing a practical guide to pharma marketers – a first of its kind event that will bring together all stakeholders and deliver a roadmap to revitalizing customer relationships. Go beyond theoretical discussions around digital innovation and discover how you can transform customer engagement with technology – and most importantly how to future-proof your business model and culture. \n\nGo beyond conventional digital: Harness innovations that solves patient and physician problems to increase your product’s value proposition and rebuild your reputation\nExceed customer expectations\, dominate the market\nEnsure the latest guidance and inspiration is always available for a generation that expects on-demand access to information – and become the go-to source for your customers\nBig data\, big deal: refine analytics for deeper insights that put you on top\nDon’t shout louder\, find smarter insights to form a deeper understanding of customer needs for differentiated\, targeted content\nSecure workforce buy-in and customer backing will follow\nInvest in your people with first-rate training and create a culture that will make your workforce want to shout about your products\, so your employees become your best advocates\n\nWith the latest case studies\, panels led by customers and out of industry expert sessions that will help you create the ultimate\, effortless customer experience– this is the event to ensure your business is ready to dominate the market. \nSome of the job roles and functions attending will be Digital\, Customer Experience\, Centers of Excellence\, Innovation Strategists\, Sales & Marketing Executives\, Patient Engagement\, IT leadership\, Brand Managers\, MCM and Innovation Heads. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2LIaO1K
URL:https://www.pharmajournalist.com/event/marketing-and-customer-experience-usa/
LOCATION:Sofitel Philadelphia Hotel\, 120 South 17Th Street\, Philadelphia\, PA\, 19103\, United States
ORGANIZER;CN="eyeforpharma%2C Lauren Robertson":MAILTO:LRobertson@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181114
DTEND;VALUE=DATE:20181116
DTSTAMP:20260515T033754
CREATED:20180630T162822Z
LAST-MODIFIED:20180807T223434Z
UID:16577-1542153600-1542326399@www.pharmajournalist.com
SUMMARY:3rd Skin Microbiome Congress
DESCRIPTION:3rd Skin Microbiome Congress | 14-15 NOVEMBER\, 2018 | LONDON\, UNITED KINGDOM \nThe average consumer uses up to 515 synthetic chemicals daily to eradicate dermalogical concerns – how can this be good for skin? Introducing the first European Skin Microbiome Congress. \n \nFollowing the success of the inaugural Skin Microbiome Congress in Boston in May and our second congress in San Francisco in September\, don’t miss the opportunity to join 200+ industry experts from multinational pharmaceutical\, beauty and personal care companies\, independent skincare brands and innovative biotechs to discuss the emerging relationship between the skin microbiome and healthy skin. \nDiscover the potential of prebiotic\, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: \nEffective Networking – Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application \nCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria\, bacterial extracts\, or active ingredients to promote & protect the skins microbiome \nConsumer Trends – Understand how consumers trends towards natural\, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome \nClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics \nCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity\, gaining market share with scientifically backed products \nRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product \nWith an increasing consumer trend towards natural products\, what’s more natural than harnessing the bacteria on your skin? Don’t miss your chance to understand the next generation of natural skincare products! \nTo learn more about 3rd Skin Microbiome Congress\, and to register online\, visit www.skinmicrobiomecongresseu.com  \nCONTACT:\n+44 (0)20 3696 2920\nevents@kisacoresearch.com
URL:https://www.pharmajournalist.com/event/3rd-skin-microbiome-congress/
LOCATION:ILEC Conference Centre and Ibis London Earls Court\, 47 Lillie Road\, London\, SW6 1UD\, United Kingdom
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181114
DTEND;VALUE=DATE:20181116
DTSTAMP:20260515T033754
CREATED:20180608T110133Z
LAST-MODIFIED:20180608T112121Z
UID:16194-1542153600-1542326399@www.pharmajournalist.com
SUMMARY:Biosimilars USA
DESCRIPTION:Building on the success of previous events\, SMi proudly announces the return of its 5th Annual Biosimilars USA Conference\, taking place in New Jersey\, USA on the 14th and 15th November 2018 and chaired by Richard DiCicco\, Chairman\, Harvest Moon Pharmaceuticals USA. \n\nThe event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S. \nFresh from the press: On March 7th\, 2018\, the U.S.-FDA’s Commissioner\, Scott Gottlieb\, MD\, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars\, accelerate your biosimilar pipeline and achieve FDA approval. \nHear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars\, as they offer a unique insight into the areas of manufacturing\, commercialization\, device design\, uptake\, switching\, interchangeability\, and regulations. \nThis event is CPD accredited. \n#SMiBioSimUSA \nPLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS\nTuesday 25th September 2018\, Copthorne Tara Hotel\, Central London\, UK \n08.30 – 12.30\nWorkshop A: Decoding how Stakeholders may Drive Biosimilar Adoption\nWorkshop Leaders: Tucker Herbert\, Manager\, ZS Associates\nChristina Corridon\, Associate Principal\, ZS Associates \n13.30 – 17.00\nWorkshop B: Dealing with Life Sciences Patents at the PTAB\nWorkshop Leaders: Ha Kung Wong\, Partner\, New York\, Fitzpatrick\, Cella\, Harpper & Scinto\nJohn Kirkland\, Director\, Intellectual Property\, Alkermes\, Inc. \nWHO SHOULD ATTEND\nMedical Directors\, Scientific Directors\, VP’s\, Directors\, Managers\, Team Leaders\, Partners\, Consultants and Attorneys of:\nBiosimilars\, Biobetters\, Biopharmaceuticals\, Biostatistics\, Business Alliances\, Business Development\, Clinical Operations\, Commercial\, Decision Analytics\, Global Intelligence\, Global Operations\, Managed Markets and Trade Relations\, Market assess\, Marketing\, Patient & Physician Services\, R&D Policy\, Regulatory Affairs\, Scientific Affairs\, and anyone else who works within the biosimilars industry! \nEARLY BIRD-RATES\nBOOK BY JUNE 29TH AND SAVE US$300\nBOOK BY SEPTEMBER 28TH AND SAVE US$100 \nTo learn more about Biosimilars USA\, and to register online\, visit www.biosimilars-usa.com/pharmajournalist 
URL:https://www.pharmajournalist.com/event/biosimilars-usa/
LOCATION:RENAISSANCE WOODBRIDGE HOTEL\, NEW JERSEY\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181112
DTEND;VALUE=DATE:20181116
DTSTAMP:20260515T033754
CREATED:20180926T135644Z
LAST-MODIFIED:20180927T081419Z
UID:17781-1541980800-1542326399@www.pharmajournalist.com
SUMMARY:World ADC San Diego
DESCRIPTION:9th Annual World ADC San Diego 2018 | 12-15 November\, 2018 | Marriott Marquis & Marina\, San Diego\, CA \nMaximizing the clinical therapeutic window of antibody-drug conjugates is a challenge we’re continuing the grapple with.  \nAs such\, there is a lot to be shared and discussed at this year’s 9th Annual World ADC San Diego. \n \nSince it’s conception in 2009 World ADC has risen to become the world’s leading and most comprehensive ADC meeting. The pinnacle event for thought-leading ADC drug developers.  \nOffering you an unparalleled learning and networking experience this year’s conference will share the very latest research advances\, enabling you to maximize the clinical therapeutic window of your ADC candidate. \nJoin over 650 drug developers across 220 organizations from the likes of Daiichi Sankyo\,Genentech\, Bristol Myers Squibb\, Immunomedics\, Immunogen\, Formation Biologics\, FDA and Sutro Biopharma to: \n\nHear unpublished data for the first time during the new Late Breaking Abstracts session\n\n\nAccess superior breadth of ADC research across 4 streams of parallel learning across discovery\, development\, clinical and manufacturing\n\n\nCommunicate your new results\, benchmark against your peers and gain invaluable feedback from the scientific community during the Poster Session\n\n\nGain tangible actions from discussing your challenges in one of the thirteen discussion led workshops\n\n\nRecognise your peer’s achievements and maybe yours?during the 5th Annual World ADC Awards ceremony\n\nFind out more https://info.hansonwade.com/worldadcsandiego \nDownload Full Agenda https://info.hansonwade.com/worldadcguide
URL:https://www.pharmajournalist.com/event/world-adc-san-diego/
LOCATION:Marriott Marquis San Diego\, 333 W Harbor Dr\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:adc@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181112
DTEND;VALUE=DATE:20181114
DTSTAMP:20260515T033754
CREATED:20180620T145701Z
LAST-MODIFIED:20180620T145701Z
UID:16379-1541980800-1542153599@www.pharmajournalist.com
SUMMARY:Superbugs & Superdrugs USA
DESCRIPTION:Antimicrobial resistance\, leading to the development of superbugs\, is a major threat to public health and continues to increase as a problem\, due to continued misuse of antibiotics. With pharmaceutical companies showing less focus on the development of new antibiotics\, several incentive initiatives have been set up – CARBX\, BARDA\, IMI (EU) – in order to encourage reinvestments. \n\nTo address the ever-growing need of informative and thought-provoking discussions\, Superbugs & Superdrugs USA conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers\, within the field. \nThis years’ Superbugs & Superdrugs USA conference programme will help participants to learn about pathogen focused drug development; discover the best methods to overcome bacterial resistance through novel modes of action; discuss the state of developments within the antifungal space; develop an understanding of funding opportunities which support antibacterial research and development; gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used within the field\, making this event the perfect platform to strengthen knowledge in key principles. \nSpeakers include: \n\nAnthony Simon Lynch\, Senior Scientific Director\, Janssen\nWilliam Weiss\, Director\, Pre-Clinical Services\, UNT Health Science Center\nTina Guina\, Program Officer\, Drug Development Section\, NIAID/NIH\nMark Albrecht\, Project Officer\, HHS/ASPR/BARDA\nAntonio DiGiandomenico\, Principal Scientist\, MedImmune\nAndrew Tomaras\, VP & Director of Microbiology\, Bacterioscan\nDan Pevear\, Sr Vice President & Director of Microbiology\, VenatoRx\nIan Friedland\, Clinical Consultant\, ex-CMO\, Achaogen\n\nPlus\, topical workshops on November 14: \n\nRapid diagnostics for drug resistance: Are we there yet?\nAvoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics\n\nFurther details at http://www.superbugs-usa.com/PJWL \nTwitter – @SMIpharm & #smibugs\nLinkedIn – SMi Pharma
URL:https://www.pharmajournalist.com/event/superbugs-superdrugs-usa/
LOCATION:Renaissance Woodbridge Hotel\, 515 US Highway 1 South\, Iselin\, NJ\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:ldurneva@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181106
DTEND;VALUE=DATE:20181109
DTSTAMP:20260515T033754
CREATED:20180830T074521Z
LAST-MODIFIED:20180830T074647Z
UID:17378-1541462400-1541721599@www.pharmajournalist.com
SUMMARY:World Orphan Drug Congress Europe 2018
DESCRIPTION:The 9th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development\, from clinical development and R&D to corporate development and market access. \n \nNow recognised as the largest and most established European orphan drug event\, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape. \nJoin us in November and make sure you are at the forefront of the orphan drug industry. Regardless of whether your interest lies in research\, clinical development\, patient access\, global pricing and reimbursement or just to engage with patient advocacy groups more intimately\, we have content\, networking and potential partners for you! \nTake just three days out of the office to meet with 500+ potential customers who need to find solutions to challenges around the commercial\, regulatory and scientific issues in orphan drugs. Through strategic keynote plenaries\, themed tracks and dedicated networking sessions\, you have the chance to really tailor the event to the needs of your day-to-day role. \nOur 2018 Advisory Board members include: \n\nWills Hughes-Wilson\, Former Senior Vice President\, Chief Patient Access Officer\, Sobi\nProfessor Michael Linden\, Former VP Gene Therapy & Head\, GMI\, Pfizer\nYann Le Cam\, Chief Executive Officer\, EURORDIS\nDr Ségolène Aymé\, Founder of Orphanet\, Emeritus Research Director\, INSERM\nDr Bruno Sepodes\, Chair of COMP\, EMA\nSheela Upadhyaya\, Assoc. Director Highly Specialised Technologies\, National Institute For Health and Care Excellence\nAlastair Kent\, Director\, Genetic Alliance UK\nDr Carlo Incerti\, SVP\, Head of Global Medical Affairs\, CMO\, Genzyme\, A Sanofi Company\nDr Birgitte Volck\, SVP\, Head of R&D Rare Diseases\, GSK\nDr Mathew Pletcher\, Head of Rare Disease Discovery\, Roche \nDr M Ken Kengatharan\, Managing Director\, Atheneos Capital  \nDr Pedro Franco\, Former Scientific Administrator\, EMA\n\nIf you are interested in attending make sure to register today and benefit from the 10% partner discount. Simply use the voucher code SPTX when you register online http://bit.ly/2LFtuiq \nContact:  \nWorld Orphan Drug Congress Europe 2018 \nT: +44 (0) 207 092 1257\nE: issa.mauthoor@terrapinn.com
URL:https://www.pharmajournalist.com/event/world-orphan-drug-congress-europe/
LOCATION:Crowne Plaza Hotel Barcelona\, Barcelona\, Spain
ORGANIZER;CN="Terrapinn":MAILTO:+44 (0) 207 092 1257
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181106
DTEND;VALUE=DATE:20181109
DTSTAMP:20260515T033754
CREATED:20180820T081448Z
LAST-MODIFIED:20180820T081448Z
UID:17271-1541462400-1541721599@www.pharmajournalist.com
SUMMARY:DigitX Healthcare Summit
DESCRIPTION:DigitX Summit focuses on strategizing marketing effectiveness and a map for successful digital transformation. Going through multi-channel and omni-channel marketing strategies\, data and analytics\, future tech and apps the summit helps define customer engagement\, patient experience and developing the connected healthcare network. \n \nTo learn more about this event\, and to register online\, visit http://healthcaredigitx.encom-global.com
URL:https://www.pharmajournalist.com/event/digitx-healthcare-summit/
LOCATION:Plaza Frankfurt Congress Hotel\, Frankfurt Am Main\, Germany
ORGANIZER;CN="Engaged Communications":MAILTO:savio.soares@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181106
DTEND;VALUE=DATE:20181109
DTSTAMP:20260515T033754
CREATED:20180820T081131Z
LAST-MODIFIED:20180820T081131Z
UID:17267-1541462400-1541721599@www.pharmajournalist.com
SUMMARY:Global Pharma Sales Summit
DESCRIPTION:The GPS Summit will provide a road map for pharma sales excellence and effectiveness. Covering themes which will discuss how data can transform sales and develop effective commercial models\, customer engagement models\, training and development for performance enhancement and provide insight into developing a competitive edge. \n \nTo learn more about this event\, and to register online\, visit http://pharmagps.encom-global.com/
URL:https://www.pharmajournalist.com/event/global-pharma-sales-summit/
LOCATION:Plaza Frankfurt Congress Hotel\, Frankfurt Am Main\, Germany
ORGANIZER;CN="Engaged Communications":MAILTO:savio.soares@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181106
DTEND;VALUE=DATE:20181109
DTSTAMP:20260515T033754
CREATED:20180820T080730Z
LAST-MODIFIED:20180820T080730Z
UID:17263-1541462400-1541721599@www.pharmajournalist.com
SUMMARY:Healthcare Market Access & Pricing Summit
DESCRIPTION:MAPS is designed to discuss strategies that enhance pricing and access. Discussing new pricing models\, capturing value and reimbursement strategies in Pharma and MedTech the event will delve into how RWE can support market access\, enhancing value for patients and effective collaboration between stakeholders. \n \nTo learn more about this event\, and to register online\, visit http://healthcaremaps.encom-global.com/
URL:https://www.pharmajournalist.com/event/healthcare-market-access-pricing-summit/
LOCATION:Plaza Frankfurt Congress Hotel\, Frankfurt Am Main\, Germany
ORGANIZER;CN="Engaged Communications":MAILTO:savio.soares@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181106
DTEND;VALUE=DATE:20181108
DTSTAMP:20260515T033754
CREATED:20180606T155736Z
LAST-MODIFIED:20180606T160300Z
UID:16120-1541462400-1541635199@www.pharmajournalist.com
SUMMARY:Independent Expert Committees Congress
DESCRIPTION:Independent Expert Committees Congress\nEndpoint Adjudication | Safety Assessment | Data Monitoring\n6-7 November 2018 • Amsterdam\, Netherlands \n\nJoin CBI’s Global Community of Clinical and Safety professionals at the Independent Experts Committee Congress\, as we collaborate to develop and share best practices for committee selection\, streamlining data collection and reporting\, navigating data privacy and GDPR\, and minimizing regulatory approval timelines. Learn more at cbinet.com/IEC \nContact:\nStuart Steller\, Sr. Professional Development Manager\nPh: +1.339.298.2158\nE: Stuart.Steller@cbinet.com
URL:https://www.pharmajournalist.com/event/independent-expert-committees-congress/
LOCATION:Amsterdam\, Netherlands
ORGANIZER;CN="CBI%2C a division of UBM Americas":MAILTO:Stuart.Steller@cbinet.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181101
DTEND;VALUE=DATE:20181103
DTSTAMP:20260515T033754
CREATED:20180712T065032Z
LAST-MODIFIED:20181015T064248Z
UID:16663-1541030400-1541203199@www.pharmajournalist.com
SUMMARY:6th Digital Pharma Marketing China 2018
DESCRIPTION:6th Digital Pharma Marketing China 2018 | 1 & 2 November 2018 | The Marriott Hotel\, Shanghai\nCHINA will be the last concluding stop to our Digital Pharma Series World Tour (after Japan\, US and UK)!\nAnd we are all set to unleash the Best Pharma Marketing Show Ever at this year’s 6th Digital Pharma Marketing China 2018 where a grand gathering of over 150+ Chief Marketing Officers\, CEOs\, Digital/IT/Sales/Brand/Project/Product Directors. As well as Key Decision Makers from China’s and Oversea’s top Pharmaceutical\, Biotech\, Hospital and Healthcare companies will take place. \n \nHear innovative strategies\, high-impact local & international expert panel sessions\, China & Global market real-life case-studies & live-project showcase\, as well as sharing of exclusive future insights from inspiring Pharma Marketing & Strategy Planning Leaders\, Digital Marketing Experts and leading Technology Innovation Specialist; plus an amazing environment served with exquisite cuisines & drinks; it is the absolute best community you could ask for at this year’s 6th Digital Pharma Marketing China 2018! \nTo learn more about this event\, and to register online\, visit http://bit.ly/digitalpharmachina \nContact:\nEmail: benjaminlee@questexasia.com\nPhone: +65 6395 4585
URL:https://www.pharmajournalist.com/event/6th-digital-pharma-marketing-china-2018/
LOCATION:The Hongta Hotel A Luxury Collection Hotel\, 上海红塔豪华精选酒店 中国上海市浦东新区东方路889号 邮政编码: 200122
ORGANIZER;CN="Questex Asia":MAILTO:benjaminlee@questexasia.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181101
DTEND;VALUE=DATE:20181103
DTSTAMP:20260515T033754
CREATED:20180201T134810Z
LAST-MODIFIED:20180201T134851Z
UID:9044-1541030400-1541203199@www.pharmajournalist.com
SUMMARY:SAPHEX
DESCRIPTION:The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry. The exhibition brings together all the key suppliers to the region’s pharmaceutical manufacturing base\, exhibitors presenting a full range of APIs\, excipients\, and drug formulations; pharmaceutical packaging solutions; processing machinery and equipment; laboratory equipment; clean room technology; and much\, much more! The exhibition attracts decision makers from all the leading pharmaceutical manufacturers in the region and from across Africa\, and provides a forum for manufacturers and their suppliers to forge long-standing\, mutually beneficial partnerships to ensure future commercial success. \nTo learn more about this event\, and to register online\, visit www.saphex.co.za
URL:https://www.pharmajournalist.com/event/saphex-2018/
LOCATION:GALLAGHER CONVENTION CENTRE\, 19 RICHARDS DRIVE\, HALFWAY HOUSE\, MIDRAND\, 1685\, South Africa
ORGANIZER;CN="Africa Pharma Event Series":MAILTO:jessica@saphex.co.za
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181030
DTEND;VALUE=DATE:20181101
DTSTAMP:20260515T033754
CREATED:20180820T084126Z
LAST-MODIFIED:20180820T084126Z
UID:17285-1540857600-1541030399@www.pharmajournalist.com
SUMMARY:Outsourcing Clinical Trials Nordics 2018
DESCRIPTION:Following on from the success of the 2017 Outsourcing in Clinical Trials Nordics conference\, Arena International is pleased to announce that the event will return for its 6th year in 2018. \n \nThe 2018 event welcomes biopharmaceutical and medical device companies from across the Nordic region to share knowledge and challenges of outsourcing and clinical operations. \nDelegates will hear from the most innovative companies in the region on how they have developed their outsourcing and clinical operations strategies. Issues such as deciphering methods to preventing time delays and outlining a rational approach between third-parties\, achieving greater financial transparency into refining collaborative terms with your partners. \nThe conference further welcomes a unique Medical Device stream which includes an array of successful Nordic companies. The stream will discuss the new MDR regulations and the challenges it has come with. There will be presentations on securing economic for start-up companies and also the opportunity to participate in a unique workshop on building a clinical expertise group specific to the Nordic region. \nThrough constant collaboration and support with members of the local industry\, this conference features the latest trends in clinical outsourcing and operational development within the medical device and pharmaceutical industry. Delegates will leave with a range of strategies and inspiration to apply to the operation running of their clinical trials. \nDon’t miss out on this unique event; register your place today! \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/octnordics
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-nordics-2018/
LOCATION:Copenhagen\, Denmark
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181029
DTEND;VALUE=DATE:20181031
DTSTAMP:20260515T033754
CREATED:20180926T085309Z
LAST-MODIFIED:20180926T085408Z
UID:17764-1540771200-1540943999@www.pharmajournalist.com
SUMMARY:Microbiome R&D and Business Collaboration Forum: USA
DESCRIPTION:As part of its worldwide microbiome series\, Global Engage is pleased to announce the 6th Microbiome R&D and Business Collaboration Forum: USA which will be held on 29-30 October\, 2018 and will be co-located with the 3rd Probiotics Congress: USA. \nLast year’s congress attracted 400 industry\, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations. \nAttendees are expected to converge on San Diego this Fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotechs and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field. \nThe Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not to be missed. \nFor more information please visit our website: http://www.global-engage.com/event/microbiome/?utm_source=pjmp \nOr email info@globalengage.co.uk
URL:https://www.pharmajournalist.com/event/microbiome-rd-and-business-collaboration-forum-usa/
LOCATION:Paradise Point Resort & Spa\, San Diego\, USA\, San Diego\, United States
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181029
DTEND;VALUE=DATE:20181031
DTSTAMP:20260515T033754
CREATED:20180502T074142Z
LAST-MODIFIED:20180502T075032Z
UID:15540-1540771200-1540943999@www.pharmajournalist.com
SUMMARY:6th Microbiome R&D and Business Collaboration Forum: USA
DESCRIPTION:The 6th Microbiome R&D and Business Collaboration Forum: USA which will be held on 29-30 October\, 2018 and will be co-located with the 3rd Probiotics Congress: USA. \nLast year’s congress attracted 400 industry\, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations. \n\nAttendees are expected to converge on San Diego this fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotech’s and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field. The Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not be missed. \nInterested? Download the agenda: http://www.global-engage.com/event/microbiome/#agenda/?utm_source=mp18
URL:https://www.pharmajournalist.com/event/6th-microbiome-rd-and-business-collaboration-forum-usa/
LOCATION:Paradise Point Resort & Spa\, San Diego
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
END:VCALENDAR